AbbVie Inc.
NUCLEAR RECEPTOR MODULATORS
Last updated:
Abstract:
The invention provides compounds of Formula (I) ##STR00001## pharmaceutically acceptable salts, thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological conditions.
Status:
Application
Type:
Utility
Filling date:
16 Oct 2019
Issue date:
6 May 2021